Over the last year, weight loss medications such as GLP-1s (such as compounded semaglutide, Ozempic or Wegovy) have become ...
Semaglutide, the active ingredient found in Ozempic and Wegovy, may reduce the risk of Alzheimer’s disease, a new study published Thursday morning finds.
Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42,000 ...